These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 47888)

  • 41. Studies on rat complement. I. Immune adherence and immune hemolysis activities of rat serum.
    Sakamoto M
    Jpn J Exp Med; 1975 Jun; 45(3):183-9. PubMed ID: 1177359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C3b inactivator of man. 3. Further purification and production of antibody to C3b INA.
    Ruddy S; Hunsicker LG; Austen KF
    J Immunol; 1972 Mar; 108(3):657-64. PubMed ID: 4622188
    [No Abstract]   [Full Text] [Related]  

  • 43. Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b.
    Fujita T; Tamura N
    J Exp Med; 1983 Apr; 157(4):1239-51. PubMed ID: 6601177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b).
    Gitlin JD; Rosen FS; Lachmann PJ
    J Exp Med; 1975 May; 141(5):1221-6. PubMed ID: 1168693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ISOLATION AND STUDY OF A FRAGMENT OF HUMAN SERUM ALBUMIN CONTAINING ONE OF THE ANTIGENIC SITES OF THE WHOLE MOLECULE.
    LAPRESLE C; WEBB T
    Biochem J; 1965 Apr; 95(1):245-51. PubMed ID: 14335810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    NILSSON UR; MUELLER-EBERHARD HJ
    J Exp Med; 1965 Aug; 122(2):277-98. PubMed ID: 14316946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Further studies on the C3b inactivator or conglutinogen activating factor (KAF).
    Lachmann PJ; Nicol P; Aston WP
    Immunochemistry; 1973 Oct; 10(10):695-700. PubMed ID: 4202955
    [No Abstract]   [Full Text] [Related]  

  • 48. Modulation of the alternative complement pathways by beta 1 H globulin.
    Whaley K; Ruddy S
    J Exp Med; 1976 Nov; 144(5):1147-63. PubMed ID: 62817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fourth component of human complement: description of a three polypeptide chain structure.
    Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1974 Nov; 140(5):1324-35. PubMed ID: 4424566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stromata.
    Hoffman EM
    Immunochemistry; 1969 May; 6(3):391-403. PubMed ID: 5786933
    [No Abstract]   [Full Text] [Related]  

  • 51. Changes in the immunochemical properties of highly purified properdin in human serum.
    Minta JO
    J Immunol; 1975 Apr; 114(4):1415-21. PubMed ID: 123262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).
    Nicol PA; Lachmann PJ
    Immunology; 1973 Feb; 24(2):259-75. PubMed ID: 4632688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action.
    Hoffmann EM
    Immunochemistry; 1969 May; 6(3):405-19. PubMed ID: 5786934
    [No Abstract]   [Full Text] [Related]  

  • 54. Purification and characterization of a macromolecular weight cofactor for C3b-inactivator, C4bC3bINA-cofactor, of human plasma.
    Nagasawa S; Stroud RM
    Mol Immunol; 1980 Nov; 17(11):1365-72. PubMed ID: 7464836
    [No Abstract]   [Full Text] [Related]  

  • 55. The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency.
    Manni JA; Müller-Eberhard HJ
    J Exp Med; 1969 Nov; 130(5):1145-60. PubMed ID: 5347695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation and characterization of a novel plasma protein which binds to activated C4 of the classical complement pathway.
    Hammer CH; Jacobs RM; Frank MM
    J Biol Chem; 1989 Feb; 264(4):2283-91. PubMed ID: 2492518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.
    Thompson RA; Lachmann PJ
    J Exp Med; 1970 Apr; 131(4):629-41. PubMed ID: 4193934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The C1-inactivator of guinea pig serum: titration, purification and characterization of the inactivator].
    Opferkuch W; Loos M; Ringelmann R
    Z Med Mikrobiol Immunol; 1971; 156(2):194-207. PubMed ID: 4995249
    [No Abstract]   [Full Text] [Related]  

  • 59. The activation of Cls with purified Clr.
    Sakai K; Stroud RM
    Immunochemistry; 1974 Apr; 11(4):191-6. PubMed ID: 4212387
    [No Abstract]   [Full Text] [Related]  

  • 60. Purification and characterisation of the fourth component of bovine complement.
    Groth DM; Wetherall JD; Umotong BA; Sparrow P; Lee IR; Carrick MJ
    Complement; 1987; 4(1):1-11. PubMed ID: 3568627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.